cp wire

CP Wire Articles

M3 Biotechnology Begins Testing of Alzheimer’s Therapy in Adults with the Disease
  • NDX-1017 is intented to halt or reverse Alzheimer's
  • It a completely different mechanism of action than other drug candidates currently in development
  • NDX-1017 addresses... read more
Thu, 09/13/18 - 09:13 am
Microbiome Company Receives Funding from Canadian Govt to Develop New Microbiome Testing Platform for Managing Chronic Disease

Microbiome Insights, Inc. is pleased to announce that it will receive a contribution of up to $190,249 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP... read more

Wed, 09/12/18 - 09:30 am
Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira
  • Switching to Tremfya at week 28 after inadequate response to Humira, led to a sustained improvement
  • Tremfya is a human monoclonal antibody


The Janssen Pharmaceutical... read more

Wed, 09/12/18 - 09:14 am
OncoResponse Books $40 Million in Series B Financing
  • New investors include Qatar Investment Authority and Redmile Group
  • Funds will be used to advance 5 drug candidates

OncoResponse announced on 9/11/18 the completion of a... read more

Tue, 09/11/18 - 09:08 am
OPKO Responds to Nasdaq Halt of Trading of Common Shares

OPKO Health, Inc. (NASDAQ:OPK) has had trading in its common stock halted by The Nasdaq Stock Market, and the exchange has advised OPKO that the halt will continue until the company responds (to... read more

Tue, 09/11/18 - 08:55 am

Pages